Relationship between hepatitis C virus infection and schistosomal liver disease: Not simply an additive effect

Journal of Gastroenterology

Volumn 36, Issue 11, 2001, Pages 753-758

  Gad, A ^a   Tanaka, E ^a   Orii, K ^a   Rokuhara, A ^a   Nooman, Z ^a   Zerwah, A H ^a   Shoair, M ^a   Yoshizawa, K ^a   Kiyosawa, K ^a  

^a SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Hepatitis C; Liver disease; Schistosomiasis

Indexed keywords

ALANINE AMINOTRANSFERASE; ANTISCHISTOSOMAL AGENT; VIRUS ANTIBODY; VIRUS RNA;

ADULT; ARTICLE; BLOOD DONOR; BLOOD TRANSFUSION; CHRONIC LIVER DISEASE; COMORBIDITY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE SEVERITY; EGYPT; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENOTYPE; HEPATITIS C; HUMAN; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCHISTOSOMIASIS; VOLUNTEER;

ADULT; ALANINE TRANSAMINASE; ANIMALS; BILIRUBIN; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPACIVIRUS; HEPATITIS B ANTIBODIES; HEPATITIS B ANTIGENS; HEPATITIS C; HEPATITIS C ANTIBODIES; HUMANS; LIVER DISEASES, PARASITIC; MALE; MIDDLE AGED; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SCHISTOSOMA; SCHISTOSOMIASIS; SERUM ALBUMIN;

EID: 0035210185     PISSN: 09441174     EISSN: None     Source Type: Journal    
DOI: 10.1007/s005350170017     Document Type: Article

References (26)

1. Variable and hypervariable domains are found in the regions of HCV corresponding to the flavivirus envelope and NSI proteins and the pestivirus envelope glycoproteins
2. Molecular biology of hepatitis C viruses: Implication for diagnosis, development and control of viral disease
3. Hepatitis C virus: Eight years old
4. Epidemiology of hepatitis C in the west
5. Schistosomiasis
6. Diseases of the liver and biliary system
7. Hepatic schistosomiasis
8. Hepatic schistosomiasis: A clinical review
9. Chronic hepatitis B in patients with schistosomiasis mansoni
10. Delta virus versus HbsAg in chronic active hepatitis and their relation to clinical laboratory and morbidity findings in Bilharzial and non-Bilharzial patients
11. Does schistosomiasis play a role in the high seroprevalence of HCV antibody among Egyptians?
12. Risk factors associated with a high seroprevalence of hepatitis C virus infection in Egyptian blood donors
13. High prevalence of hepatitis C in Egyptian patients with chronic liver disease
14. Chronic liver disease in the Alexandria governorate, Egypt: Contribution of schistosomiasis and hepatitis virus infections
15. The epidemiology of Schistosoma mansoni, hepatitis B and hepatitis C infection in Egypt
16. Hepatitis C virus infection in a community in the Nile delta: Risk factors for seropositivity
17. Clinical, virological and histopathological features: Long-term follow-up in patients with chronic hepatitis C co-infected with S. mansoni
18. The use and limitation of ultrasonography in the diagnosis of liver morbidity attributable to Schistosoma mansoni infection in community based surveys
19. Liver
20. Viral and host factors that contribute to efficacy of interferon therapy in patients with chronic hepatitis C
21. A proposed system for the nomenclature of hepatitis C viral genotypes
22. Parenteral anti-schistosomal therapy: A potential risk factor for hepatitis B infection
23. The role of parenteral antischistosomal therapy in the spread of hepatitis C virus in Egypt
24. Anti-HCV-positive cirrhosis associated with schistosomiasis
25. Severe hepatic fibrosis in Schistosoma mansoni infection is controlled by a major locus that is closely linked to the interferon-gama receptor gene
26. + T lymphocytes in acute and chronic hepatitis C